55 related articles for article (PubMed ID: 21119366)
1. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Takano M; Sugiyama T; Yaegashi N; Sagae S; Kuzuya K; Udagawa Y; Tsuda H; Suzuki M; Kigawa J; Goto T; Tsuda H; Moriya T; Kikuchi Y
Int J Gynecol Cancer; 2010 Dec; 20(9):1506-10. PubMed ID: 21119366
[TBL] [Abstract][Full Text] [Related]
2. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
3. Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives.
Mabuchi S; Sugiyama T; Kimura T
J Gynecol Oncol; 2016 May; 27(3):e31. PubMed ID: 27029752
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
[TBL] [Abstract][Full Text] [Related]
7. Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma.
Hogen L; Vicus D; Ferguson SE; Gien LT; Nofech-Mozes S; Lennox GK; Bernardini MQ
Int J Gynecol Cancer; 2019 Sep; 29(7):1164-1169. PubMed ID: 31273067
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.
Nasioudis D; Mastroyannis SA; Albright BB; Haggerty AF; Ko EM; Latif NA
Gynecol Oncol; 2018 Jul; 150(1):14-18. PubMed ID: 29751993
[TBL] [Abstract][Full Text] [Related]
9. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
[TBL] [Abstract][Full Text] [Related]
10. Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
Sugiyama T; Okamoto A; Enomoto T; Hamano T; Aotani E; Terao Y; Suzuki N; Mikami M; Yaegashi N; Kato K; Yoshikawa H; Yokoyama Y; Tanabe H; Nishino K; Nomura H; Kim JW; Kim BG; Pignata S; Alexandre J; Green J; Isonishi S; Terauchi F; Fujiwara K; Aoki D
J Clin Oncol; 2016 Aug; 34(24):2881-7. PubMed ID: 27400948
[TBL] [Abstract][Full Text] [Related]
11. Clear-cell carcinoma of the ovary.
Fujiwara K; Shintani D; Nishikawa T
Ann Oncol; 2016 Apr; 27 Suppl 1():i50-i52. PubMed ID: 27141072
[TBL] [Abstract][Full Text] [Related]
12. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer.
Liu Z; Jing C; Kong F
J Ovarian Res; 2024 Feb; 17(1):39. PubMed ID: 38347608
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M; Long K; Rubinstein MM; Sonoda Y; Alektiar K; Weigelt B; Zivanovic O; Grisham RN
Int J Gynecol Cancer; 2022 Dec; 32(12):1576-1582. PubMed ID: 36368707
[TBL] [Abstract][Full Text] [Related]
14. Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis.
Pergialiotis V; Liatsou E; Rouvali A; Haidopoulos D; Efthymios D; Liontos M; Rodolakis A; Thomakos N
Curr Oncol; 2022 Aug; 29(8):5763-5773. PubMed ID: 36005192
[TBL] [Abstract][Full Text] [Related]
15. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
Yin M; Yang J; Zhou H; Liu Q; Li S; Zhang X
Front Oncol; 2022; 12():811638. PubMed ID: 35656506
[TBL] [Abstract][Full Text] [Related]
16. Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis.
Ikeda Y; Yoshihara M; Yoshikawa N; Yokoi A; Tamauchi S; Nishino K; Niimi K; Kajiyama H
BMC Womens Health; 2022 Mar; 22(1):80. PubMed ID: 35313889
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
[TBL] [Abstract][Full Text] [Related]
18. Clear Cell Carcinoma Arising in an Abdominal Wall Cesarean Section Scar: A Case Report With Description of Pathological and Molecular Features.
Colarossi C; Picardo MC; Colarossi L; Deiana E; D'Agata C; Fichera C; Aiello E; Giannone G; Memeo L
Front Surg; 2021; 8():735381. PubMed ID: 34595205
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma.
Tate S; Nishikimi K; Matsuoka A; Otsuka S; Shiko Y; Ozawa Y; Kawasaki Y; Shozu M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202220
[TBL] [Abstract][Full Text] [Related]
20. Is There a Survival Benefit for Patients with Advanced Ovarian Clear Cell Carcinoma Who Complete More Than 6 Cycles of Postoperative Chemotherapy?
Wang J; Shi Y; Liu Y; Li W; Jiang H; Cai H
Cancer Manag Res; 2020; 12():11631-11638. PubMed ID: 33223852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
